Scott N Boyle insider trades
Open-market stock purchases and sales by Scott N Boyle, Chief Business Officer at C4 Therapeutics, Inc, from SEC Form 4 filings since May 25, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 14, 2026 | CCCC C4 Therapeutics, Inc | Bought (not open market) | — |
| Feb 14, 2026 | CCCC C4 Therapeutics, Inc | Sold (not open market) | $13.7K |
| Feb 13, 2026 | CCCC C4 Therapeutics, Inc | Bought (not open market) | — |
| Feb 13, 2026 | CCCC C4 Therapeutics, Inc | Bought (not open market) | — |
| Feb 13, 2026 | CCCC C4 Therapeutics, Inc | Sold (not open market) | $3.3K |
Companies traded
- CCCC C4 Therapeutics, Inc: 2 sales, last Feb 14, 2026